Rocket Pharmaceuticals Inc


Market Cap$2.75B

Compare Rocket Pharmaceuticals

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Rocket Pharmaceuticals IncRocket Pharmaceuticals Inc00%---
marketMarket Avg49.51.28%13%6.20.1
HealthcareHealthcare Avg31.91.26%18%7.50.9

Current Fair Value

11.4% upside

Undervalued by 11.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.75 Billion
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.0
Outstanding Shares90,158,895
Avg 30 Day Volume715,267


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income-
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

ESG Score

No data

About Rocket Pharmaceuticals Inc

151 employees
CEO: Gaurav Shah